Physician profile
James C Wurzer
NPI 1659311934
$697.64
in general payments reported to CMS, 2019-2025
17 companies · $124 in 2025
The $124 reported for 2025 was less than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $90.99 · 2020: $13.25 · 2021: $18.31 · 2022: $70.15 · 2023: $144 · 2024: $237 · 2025: $124.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $505.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $504.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novocure INC. | $156.12 | 2024 | Optune |
| Janssen Pharmaceuticals, INC | $90.99 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $80.91 | 2023-2025 | |
| Myriad Genetic Laboratories, INC. | $67.63 | 2022-2025 | Prolaris |
| Novartis Pharmaceuticals Corporation | $48.79 | 2025 | |
| Siemens Medical Solutions USA, INC. | $44.34 | 2023 | Varian Ethos Treatment Planning |
| Aveo Pharmaceuticals, INC. | $24.34 | 2023 | Fotivda |
| Mevion_medical_systems_inc | $22.76 | 2023 | Pts250 |
| Teleflex LLC | $21.02 | 2024 | |
| Accuray Incorporated | $20.95 | 2022 | |
| Bioprotect Medical, INC. | $19.90 | 2025 | Bioprotect Balloon Implant System |
| Progenics Pharmaceuticals, INC. | $18.96 | 2022 | |
| Boston Scientific Corporation | $18.31 | 2021 | |
| Abbvie INC. | $17.00 | 2024 | |
| Pharmacyclics LLC, An Abbvie Company | $16.66 | 2023 | Imbruvica |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $15.71 | 2022 | |
| Q Biomed INC. | $13.25 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Wurzer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.